Evaluation of therapeutic effect and cytokine change during transplacental Digoxin treatment for fetal heart failure associated with fetal tachycardia, a case-control study

Int J Cardiol. 2013 Nov 15;169(4):e62-4. doi: 10.1016/j.ijcard.2013.08.130. Epub 2013 Sep 8.
No abstract available

Keywords: Cardiovascular profile score; Cytokine; Digoxin; Transplacental therapy.

Publication types

  • Evaluation Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Arrhythmia Agents / administration & dosage*
  • Biomarkers / blood
  • Blood Transfusion, Intrauterine
  • Case-Control Studies
  • Cytokines / blood*
  • Digoxin / administration & dosage*
  • Female
  • Fetal Diseases / blood
  • Fetal Diseases / drug therapy
  • Heart Failure / blood*
  • Heart Failure / drug therapy
  • Humans
  • Infant, Newborn
  • Male
  • Pregnancy
  • Tachycardia / blood*
  • Tachycardia / drug therapy
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Arrhythmia Agents
  • Biomarkers
  • Cytokines
  • Digoxin